Zepp Health (ZEPP) revenue and earnings history
Zepp Health reported revenue of $259M for fiscal 2025 (year ended Dec 31, 2025), +41.8% on the year before, and net income of −$40.1M.
Over 8 years, from fiscal 2017 to fiscal 2025, revenue grew at a compound rate of −2.4% a year.
Revenue and net income, 9 fiscal years
Annual figures, newest first
| Fiscal year | Revenue | Operating income | Net income | Operating cash flow | Capital expenditure | Free cash flow | Stock-based pay | Share buybacks | Dividends paid | Cash at year end | Total debt at year end | Report |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025ended Dec 31, 2025 | $259M+41.8% | −$29.2M | −$40.1M | −$25.7M | $516K | −$26.2M | $2.49M | $1.24M | — | $57M | $59.5M | 20-F |
| 2024 |
The latest quarter, insider trades and fund moves: Zepp Health (ZEPP) on OQRO.
Common questions
What was Zepp Health's revenue in fiscal 2025?
$259M for the year ended Dec 31, 2025, as reported in its 20-F filed Apr 24, 2026. That is +41.8% on fiscal 2024 ($183M).
How fast has Zepp Health's revenue grown?
From $315M in fiscal 2017 to $259M in fiscal 2025: a compound annual growth rate of −2.4% over 8 years. This is arithmetic on the filed figures and says nothing about the years ahead.
Where these figures come from
The SEC’s companyfacts data: every figure Zepp Health tagged in XBRL in its annual and quarterly reports since 2009 (some reports carry a few earlier years as comparatives). For each fiscal year OQRO keeps the twelve-month totals from the annual report and the cash and debt at year end, and when a later report restates a year, the later figure. Read again whenever the company files.
Figures are as reported, in US dollars, with no adjustment for acquisitions, disposals or one-off items. Earnings per share are left out because a stock split changes them between reports. This page describes the past and is not investment advice. No language model wrote it.
